21-23 PCol 1

Cards (44)

  • Analgesics
    Drugs designed to relieve pain without causing the loss of consciousness
  • Anti-inflammatory analgesics
    • Reduce inflammation
  • Opioid analgesics
    • Change the way the brain perceives pain by interacting with opioid receptors
  • Drug Classifications
    • Opioids (CNS)
    • Nonopioids (PNS)
  • Opioids
    • Natural opioids
    • Semisynthetic opioids
    • Synthetic opioids
  • Opioids
    Have a narcotic effect, inducing sedation and effective for managing many types of pain
  • Opioid receptors
    • Found extensively in the brain, spinal cord, vascular system, gut, lungs, airway, cardiac system, and some immune system cells
  • Natural (Endogenous) Opioid peptides
    • Enkephalins
    • Endorphins
    • Endomorphine
    • Dynorphine
  • Opioid receptors
    • Mu (u)
    • Kappa (k)
    • Delta (δ)
  • Mu (u) receptors

    Responsible for majority of narcotic effects such as euphoria, sedation, addiction, miosis, constipation and respiratory depression
  • Kappa (k) receptors
    Produce additional analgesia in women, activation produces dysphoria
  • Delta (δ) receptors

    Induce spinal analgesia and modulation of rapid tolerance to mu (u) opioid agonists, bind to enkephalins
  • Opioid overdose symptoms
    • Coma
    • Miosis (pinpoint pupils)
    • Respiratory depression
  • Naloxone (Narcan®)

    An opioid antagonist used to reverse the toxic effects induced by opioids
  • Approved clinical uses of opioids
    • Analgesics
    • Anesthetic agents
    • Antidiarrheals (Loperamide, Diphenoxylate)
    • Antitussive agents (Dextromethorphan)
  • Morphine
    Standard of comparison as analgesic, extensive first pass effect, poor oral bioavailability (25-30% BA)
  • Codeine
    Standard of comparison as antitussive drug, weaker analgesic than morphine
  • Thebaine
    Precursor in synthesis of Naloxone
  • Heroin/Diacetylmorphine/Diamorphine
    Recreational purpose, common drug of abuse
  • Apomorphine
    Degradation product of morphine, not analgesic because it doesn't bind to u receptors, antiparkinson drug: D2 agonists, emetic drug for oral poisoning
  • Hydromorphone, Oxymorphone
    1. 12x more potent than morphine
  • Hydrocodone, Oxycodone
    1. 12x more potent than codeine
  • Levorphanol
    1. 7x more potent than morphine, D-isomer: Dextromethorphan (antitussive)
  • Loperamide, diphenoxylate
    Antidiarrheal agents
  • Tramadol
    Weak u derivative of codeine
  • Fentanyl, Alfentanyl, Sulfentanyl
    100x more potent than morphine
  • Pentazocine
    Partial kappa agonist, u antagonist if combined with full agonist
  • Methadone
    Same efficacy as morphine, good oral BA, longer duration of action, used to wean off patients addicted to Morphine and Heroin
  • Meperidine/Pethidine (Demerol®)
    No cardiac and biliary effects, toxic metabolite: Normeperidine can cross BBB and causes seizure
  • Phenacetin
    Prodrug metabolized into active drug Acetaminophen, withdrawn due to nephrotoxicity and methemoglobinemia
  • Acetaminophen
    Weak PG synthesis inhibitor in the periphery by blocking Cyclooxygenase, used as analgesic agent and antipyretic, safe for pregnant and lactating women, toxic effect: hepatotoxicity (NAPQI)
  • Nonsteroidal anti-inflammatory drugs (NSAIDs)

    Weak organic acids that inhibit prostaglandin synthesis by blocking the cyclooxygenase enzyme
  • NSAID classifications
    • Nonselective NSAIDs (inhibit both COX-1 and COX-2)
    • Selective NSAIDs (inhibit only COX-2)
  • Cyclooxygenase (COX)

    Central enzyme involved in the synthesis of prostanoids from Arachidonic acid, COX-1 involved in production of prostanoids under normal physiologic conditions, COX-2 involved in production of prostanoids in the presence of inflammation and at sites of chronic disease
  • Aspirin (Acetylsalicylic acid or ASA)
    Prototype NSAID, irreversible COX inhibitor, adverse effects: gastritis, reversible decrease in GFR, hypersensitivity reactions, hyperuricemia and uricosuria
  • Phenylbutazone, Dipyrone, Sulfinpyrazone
    Powerful analgesic and anti-inflammatory, withdrawn due to hematotoxicities and nephrotoxicities
  • Indomethacin
    Blocks COX-1 > COX-2, higher risks of GI effects
  • Tolmentin
    Uricosuric, contraindicated in gout
  • Sulindac, Diclofenac, Ketorolac, Etodolac, Nabumetone
    Phenylacetic acid derivative NSAIDs, Sulindac may cause toxicity like Steven-Johnson Syndrome and Toxic epidermal necrolysis, Ketorolac commonly used for acute pain after surgery, reduces opioid dose requirements by 25% when co-administered
  • Mefenamic acid, Meclofenamic acid
    Fenamate NSAIDs, analgesics only, maximum use: 5 days